IRADIMED CORPORATION (IRMD) P/S ratio

P/S ratio today
12.8×

IRADIMED CORPORATION (IRMD) trades at 12.8× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 14.9×. That is 55.4% higher than the 9.6× of fiscal 2024. Figures as of 18 Nov 2026, 12:56 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/S ratio today
12.8×
P/S ratio, fiscal 2025
14.9×
Change on fiscal 2024
+55.4%
Highest on record
14.9×fiscal 2025
Lowest on record
4.1×fiscal 2016
Fiscal years on record
122014–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

IRADIMED CORPORATION P/S ratio, in more detail

Today's figure is 14.2% below the fiscal 2025 year-end.

Across the 12 fiscal year-ends on record (2014–2025), the highest was 14.9× in fiscal 2025 and the lowest 4.1× in fiscal 2016. Today's P/S ratio is higher than at 83% of the 12 fiscal year-ends on record; their median is 9.1×.

History · 12 fiscal years

P/S ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

IRADIMED CORPORATION P/S ratio, year by year

IRADIMED CORPORATION (IRMD) P/S ratio by fiscal year
Fiscal yearP/S ratioChangeYear endedShare price at year-endRevenue per share
Today12.8×—$83.45—
202514.9× 55.4% up$97.28$6.52
20249.6× 4.2% up$55.00$5.73
20239.2× 37.4% up$47.47$5.15
20226.7× 51.8% down$28.29$4.22
202113.9× 55.6% up$46.21$3.32
20208.9× 20.0% up$22.80$2.55
20197.5× 23.4% down$23.38$3.14
20189.7× 26.5% up$24.46$2.51
20177.7× 87.8% up$15.15$1.97
20164.1× 63.2% down$11.10$2.71
201511.1× 32.3% up$28.03$2.52
20148.4×—$12.90$1.53
2013———$1.31

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

More on IRMD

IRADIMED CORPORATION, figure by figure

IRADIMED CORPORATION (IRMD) overview: price, valuation and scorecard

IRADIMED CORPORATION P/S ratio: questions and answers

What is IRADIMED CORPORATION's P/S ratio?

IRADIMED CORPORATION (IRMD) trades at 12.8× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 14.9×. That is 55.4% higher than the 9.6× of fiscal 2024.

Is IRADIMED CORPORATION's P/S ratio high or low compared with its own history?

Today's P/S ratio is higher than at 83% of the 12 fiscal year-ends on record; their median is 9.1×.

What are the highest and lowest P/S ratio figures on record for IRADIMED CORPORATION?

Across the 12 fiscal year-ends on record (2014–2025), the highest was 14.9× in fiscal 2025 and the lowest 4.1× in fiscal 2016.

How is IRADIMED CORPORATION's P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end. For IRADIMED CORPORATION it is on record here for 12 fiscal years, 2014 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “IRADIMED CORPORATION (IRMD) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/IRMD/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.